Retension Pharmaceuticals
PrivateLast Round
Series B
Aug 6, 2025
Total Funding Raised
$25.4M
Company Overview
Retension Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing therapies for the treatment of hypertension and other serious cardiovascular conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Retension Pharmaceuticals Comps
Public and private peers based on sector, stage, and business model.
Retension Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Aug 6, 2025 | ||||
| Series A | Aug 21, 2024 |
Retension Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Collage Venture Partners | Series A, Series B |
| Transhuman Capital | Series B |
| Green Park & Golf Ventures | Series B |
Retension Pharmaceuticals Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Retension Pharmaceuticals's valuation, stock price, and market status.
